These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 33452661)

  • 1. Incidence and risk factors of venous thromboembolism in ANCA-associated vasculitis: a metaanalysis and metaregression.
    Hansrivijit P; Trongtorsak A; Gadhiya KP; Lnu K; Dimech CT; Thongprayoon C; Cheungpasitporn W; Lecker SH
    Clin Rheumatol; 2021 Jul; 40(7):2843-2853. PubMed ID: 33452661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Pulmonary Hemorrhage, Positive Proteinase 3, and Urinary Red Blood Cell Casts With Venous Thromboembolism in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Kronbichler A; Leierer J; Shin JI; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CGM; St Clair EW; Brunetta P; Fervenza FC; Geetha D; Keogh KA; Monach PA; Ytterberg SR; Mayer G; Specks U; Stone JH;
    Arthritis Rheumatol; 2019 Nov; 71(11):1888-1893. PubMed ID: 31216123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venous Thrombotic Events in ANCA-Associated Vasculitis: Incidence and Risk Factors.
    Isaacs B; Gapud EJ; Antiochos B; Seo P; Geetha D
    Kidney360; 2020 Apr; 1(4):258-262. PubMed ID: 35372925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thromboembolism in ANCA-associated vasculitis: a population-based cohort study.
    Liapi M; Jayne D; Merkel PA; Segelmark M; Mohammad AJ
    Rheumatology (Oxford); 2021 Oct; 60(10):4616-4623. PubMed ID: 33506869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of venous thromboembolic events with skin, pulmonary and kidney involvement in ANCA-associated vasculitis: a multinational study.
    Moiseev S; Kronbichler A; Makarov E; Bulanov N; Crnogorac M; Direskeneli H; Galesic K; Gazel U; Geetha D; Guillevin L; Hrušková Z; Little MA; Ahmed A; McAdoo SP; Mohammad AJ; Moran S; Novikov P; Pusey CD; Rahmattulla C; Satrapová V; Silva J; Terrier B; Tesař V; Westman K; Jayne DRW
    Rheumatology (Oxford); 2021 Oct; 60(10):4654-4661. PubMed ID: 33523099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study.
    Kim SM; Choi SY; Kim SY; Kim J
    Rheumatol Int; 2019 Nov; 39(11):1919-1926. PubMed ID: 31552433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of positive anti-neutrophil cytoplasmic antibodies without evidence of anti-neutrophil cytoplasmic antibodies-associated vasculitis.
    Bornstein G; Ben-Zvi I; Furie N; Grossman C
    Int J Rheum Dis; 2019 May; 22(5):940-945. PubMed ID: 30729688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of PR3- and MPO-ANCA autoantibody specificity changes in ANCA-associated vasculitis.
    Holding S; Fisher VJ; Abuzakouk M
    Ann Clin Biochem; 2015 Mar; 52(Pt 2):297-301. PubMed ID: 24723621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous thromboembolism in ANCA-associated vasculitis--incidence and risk factors.
    Stassen PM; Derks RP; Kallenberg CG; Stegeman CA
    Rheumatology (Oxford); 2008 Apr; 47(4):530-4. PubMed ID: 18356178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A population-based study showing better renal prognosis for proteinase 3 antineutrophil cytoplasmic antibody (ANCA)-associated nephritis versus myeloperoxidase ANCA-associated nephritis.
    Mohammad AJ; Segelmark M
    J Rheumatol; 2014 Jul; 41(7):1366-73. PubMed ID: 24882836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between serologic profile (ANCA type) and clinical features of renal involvement in ANCA-associated vasculitides.
    Bulanov NM; Makarov EA; Shchegoleva EM; Zykova AS; Vinogradova ES; Novikov PI; Lysenko Kozlovskaya LV; Moiseev SV
    Ter Arkh; 2018 Jun; 90(6):15-21. PubMed ID: 30701899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis.
    Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):111-118. PubMed ID: 28339364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies.
    Choi HK; Liu S; Merkel PA; Colditz GA; Niles JL
    J Rheumatol; 2001 Jul; 28(7):1584-90. PubMed ID: 11469466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Difference in relapse-rate and clinical phenotype by autoantibody-subtype in Japanese patients with anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Murosaki T; Sato T; Akiyama Y; Nagatani K; Minota S
    Mod Rheumatol; 2017 Jan; 27(1):95-101. PubMed ID: 27320904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloperoxidase-antineutrophil Cytoplasmic Antibodies (MPO-ANCA) and Proteinase 3-ANCA without Immunofluorescent ANCA Found by Routine Clinical Testing.
    Rao DA; Wei K; Merola JF; O'Brien WR; Takvorian SU; Dellaripa PF; Schur PH
    J Rheumatol; 2015 May; 42(5):847-52. PubMed ID: 25834211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and outcomes of small airway disease in ANCA-associated vasculitis.
    Zhou P; Gao L; Li Z; Que C; Li H; Ma J; Wang G
    Respirology; 2024 Feb; 29(2):146-157. PubMed ID: 37857408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of Cardiovascular Disease and Venous Thromboembolism Among Patients With Incident ANCA-Associated Vasculitis: A 20-Year Population-Based Cohort Study.
    Berti A; Matteson EL; Crowson CS; Specks U; Cornec D
    Mayo Clin Proc; 2018 May; 93(5):597-606. PubMed ID: 29588079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Berti A; Warner R; Johnson K; Cornec D; Schroeder D; Kabat B; Langford CA; Hoffman GS; Fervenza FC; Kallenberg CGM; Seo P; Spiera R; St Clair EW; Brunetta P; Stone JH; Merkel PA; Specks U; Monach PA;
    Arthritis Rheumatol; 2018 Jul; 70(7):1114-1121. PubMed ID: 29693324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients.
    Geffriaud-Ricouard C; Noël LH; Chauveau D; Houhou S; Grünfeld JP; Lesavre P
    Clin Nephrol; 1993 Mar; 39(3):125-36. PubMed ID: 7681736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A preliminary study of the significance of autoantibodies against light chain of myeloperoxidase on pulmonary damages in myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].
    Zhang L; Shuai Z; Hu Z; Zhang M; Chen S
    Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):511-6. PubMed ID: 26359012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.